Potential Combination Therapy Approaches with Ruxolitinib in Myelofibrosis
April 26th 2023A review of recent trial data evaluating combination therapy approaches with ruxolitinib in myelofibrosis, including the rationale and potential clinical benefits associated with the use of these emerging strategies.
Read More
PSMA-PET Plus Multi-Parametric MRI Aids Detection of Clinically Significant Prostate Cancer
Enzalutamide Improves Undetectable PSA Rates Alone and With Leuprolide in Nonmetastatic CSPC
Dr Shore on the Importance of a Multidisciplinary Team in Urologic Oncology
Apalutamide/ADT Demonstrates 100% Biochemical RFS Rate in High-Risk Prostate Cancer
2 Commerce Drive
Cranbury, NJ 08512